Beriate (Human Coagulation Factor Viii)

Beriate is a human coagulation factor VIII used to manage bleeding episodes in hemophilia A. This intravenous medication supports blood clotting and is derived from plasma.

Beriate is primarily used to control bleeding in individuals with hemophilia A, a condition where the body lacks sufficient factor VIII. It is also used to prevent bleeding during surgeries or dental procedures in these patients. The medication works by replacing the missing clotting factor, helping the blood to clot properly.

Common effects of Beriate may include mild reactions at the injection site, such as redness or swelling. Some users might experience headaches, nausea, or dizziness. Severe allergic reactions are rare but require immediate medical attention.

Beriate should be used under medical supervision. Patients with a history of allergic reactions to factor VIII products should use it with caution. It is essential to follow proper handling and storage guidelines to maintain its effectiveness.

Beriate may interact with certain medications, including those that affect blood clotting. Always inform your healthcare provider about all medications you are taking. Avoid using it with desmopressin without medical advice.